Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults

  • Technology appraisal guidance
  • TA157
  • Published: 
Download guidance (PDF)

1 Recommendations

1.1

Dabigatran etexilate, within its marketing authorisation, is recommended as an option for the primary prevention of venous thromboembolic events in adults who have undergone elective total hip replacement surgery or elective total knee replacement surgery.